PAR and ApoB/ApoA1 are independent prognostic factors for 5-year overall survival; Lower ApoA1 levels associated with worse survival through macrophage transformation and enhanced tumor-promoting inflammation. The gene discussed is APOA1; the disease is neoplasm.